Advance Research

Advance Research

We are working to drive research to better treatments, and ultimately a cure, as quickly as possible

From basic science to clinical trial designs, the National Brain Tumor Society partners with the world’s leaders in research, public policy, and clinical care to advance the understanding of brain tumors, expand the availability of new treatments, and drive the discovery of a cure. With targeted programs for both adult and pediatric brain tumors, as well as other strategic initiatives to improve access and approvals of newfound discoveries, we drive bold, innovative programs to ensure a brighter future.

Integrated Initiatives

Integrated Initiatives

Uniquely poised to drive change and progress throughout the drug discovery and development pipeline, our initiatives and programs further knowledge and deliver results to our community.

Our funding strategy

Our Funding Strategy

Driven by the needs of this community, we have funded more than $30 million dollars of promising and innovative research for both adults and pediatric brain tumors.

Research funding opportunities

Funding Opportunities

Our innovative funding models are designed to support rigorous scientific investigation and drive progress toward treatments and the discovery of a cure.


From the Blog

  • July 24, 2015

    Update on the Oligodendroglioma Research Fund

    nci-vol-3697-300

    In 2011, the National Brain Tumor Society launched our Community Research Fund (CRF) model. The goal of the model was to allow groups of donors with a common interest to pool their funding together and fund research in an area that wa

    Read More

  • July 23, 2015

    Precision Medicine Conference Highlights

    precisjen-e1437675013280

    Precision medicine, also referred to as personalized or individualized medicine, is defined on Wikipedia as “a medical model that proposes the customization of healthcare—with medical decisions, practices, and/or pro

    Read More

  • July 15, 2015

    National Brain Tumor Society Appoints David Arons Interim Chief Executive Officer

    National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, has today appointed David Arons, JD, as interim Chief Executive Officer. Mr. Arons has served as Chief Public Policy and Advocacy Officer at the National Brain Tumor Society for the past four years. “We are excited to […]

    Read More

More from the blog